Coronary-artery stents.

By Patrick W. Serruys, M. Kutryk, A. Ong. New England Journal of Medicine, 2006

887 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Coronary stents: current status. (2010, neutral): “2% of CI procedures (17); however, despite their obvious advanages, there were associated problems and concerns.”
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential (2006, background): “Although the incidence of restenosis has been reduced to 20–30% by the use of modern stents, which have further revolutionized angioplasty procedures, it remains a significant clinical problem with a limited number of therapeutic option”
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. (2008, background): “However, injury to the tunicamedia results in excessive neointimal hyperplasia in approximately 20% to 30% of patients treated with bare-metal stents, whichresults in recurrent ischemiaoften necessitating rehospitalization for repeat percutaneous coronary intervention or coronary artery bypass graft”